Please provide your email address to receive an email when new articles are posted on . Six years of treatment reduced axial growth by 0.52 mm, while 3 years of treatment reduced growth by 0.19 mm.

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. SAN DIEGO — Data from a 7-year clinical study of the ...

The first contact lens designed to slow down the progression of nearsightedness in children will hit the market in March. The U.S. Food and Drug Administration recently approved the MiSight contact ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

Becomes the First and Only FDA Approved Contact Lens of its Kind in the U.S. SAN RAMON, Calif., Nov. 18, 2019 (GLOBE NEWSWIRE) -- CooperCompanies (NYSE: COO), announced today that CooperVision has ...

SAN RAMON, Calif., Oct. 9, 2020 /PRNewswire/ -- CooperVision is reporting the latest findings from its landmark MiSight® 1 day clinical study, providing new insights about myopia management and the ...

ROCHESTER, N.Y., Feb. 10, 2026 /PRNewswire/ -- CooperVision today announced immediate availability of its MiSight ® 1 day * myopia control contact lens in Japan, where as many as 77% of elementary ...

In the study’s seventh year, participants were transitioned from MiSight ® 1 day to a single vision contact lens to evaluate if treatment gains would be retained. Myopic progression then occurred only ...

SAN RAMON, CALIF., March 10, 2022—A new peer review paper affirms that CooperVision ® MiSight ® 1 day contact lenses provide myopia control for nearly all children. †1 In the longest-running soft ...

MiSight® 1 day is the first soft contact lens authorized by Japan's Ministry of Health, Labor and Welfare for use by children to correct myopia and control its progression.†‡3 "This milestone ...